SGH
EHAB

Sivik Global Healthcare’s Enhabit EHAB Stock Holding History

Sivik Global Healthcare’s Portfolio EHAB Stock Details EHAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-62,594
Closed -$879K – 43
2022
Q3 		$879K Buy
+62,594
New +$1.01M 0.49% 41

Other funds holding EHAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Sivik Global Healthcare's EHAB Position: Q4 2022 in Review

Sivik Global Healthcare sold out of Enhabit (EHAB) in Q4 2022, closing a stake of 62,594 shares — an estimated $879K sold.

Sivik Global Healthcare first reported a position in EHAB in Q3 2022 and held it in 1 quarter. The position peaked at $879K in Q3 2022. 212 funds tracked by Wall St. Rank hold EHAB as of Q4 2022.

  • Sivik Global Healthcare reported no remaining Enhabit position as of Q4 2022 after selling out during the quarter.
  • Sivik Global Healthcare sold 62,594 Enhabit shares in Q4 2022, an estimated $879K.
  • Sivik Global Healthcare first reported a position in Enhabit in Q3 2022 and held it in 1 quarter.
  • Sivik Global Healthcare's Enhabit position peaked at $879K in Q3 2022.
  • 212 funds tracked by Wall St. Rank held Enhabit as of Q4 2022.

Based on Sivik Global Healthcare's 13F filing for Q4 2022, filed 8 Feb 2023.